TerrAscend (TSNDF) Other Working Capital Changes (2021 - 2024)
TerrAscend's (TSNDF) quarterly Other Working Capital Changes came in at -$15000.0 in Q1 2026, down 107.18% year-on-year from $209000.0 in Q1 2025, and down 107.65% on a QoQ basis from $196000.0 in Q4 2025.
TerrAscend (TSNDF) Other Working Capital Changes (2021 - 2024) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Other Working Capital Changes data on file, last reported at -$15000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 107.18% year-over-year to -$15000.0 in Q1 2026; TTM through Mar 2026 was $368000.0, a 150.34% increase from a year earlier, with the FY2025 full-year figure at $592000.0, down 26.09% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$15000.0, down from $196000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for TSNDF reached as high as $4.6 million in Q3 2021 and fell as low as -$3.5 million in Q4 2021.
- Historically, Other Working Capital Changes has averaged -$57333.3 across 4 years, with a median of -$4000.0 in 2023.
- Across the five-year window, Other Working Capital Changes soared 225900.0% in 2023 and sank 1075.85% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at $1000.0 in 2022, then surged by 225900.0% to $2.3 million in 2023, then plunged by 103.32% to -$75000.0 in 2024, then jumped by 361.33% to $196000.0 in 2025, then tumbled by 107.65% to -$15000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$15000.0 in Q1 2026, $196000.0 in Q4 2025, and $486000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Jun 30, 2024 | -89,000.00 |
| Jun 30, 2024 | -89,000.00 |
| Jun 30, 2024 | -89,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | -845,000.00 |
| Jun 30, 2023 | -845,000.00 |
| Jun 30, 2023 | -845,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Mar 31, 2023 | 131,000.00 |